These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11953643)

  • 41. Minimal interruption of cardiopulmonary resuscitation for a single shock as mandated by automated external defibrillations does not compromise outcomes in a porcine model of cardiac arrest and resuscitation.
    Ristagno G; Tang W; Russell JK; Jorgenson D; Wang H; Sun S; Weil MH
    Crit Care Med; 2008 Nov; 36(11):3048-53. PubMed ID: 18824916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of epinephrine on outcomes of normothermic and therapeutic hypothermic cardiopulmonary resuscitation.
    Sun S; Tang W; Song F; Yu T; Ristagno G; Shan Y; Weng Y; Weil MH
    Crit Care Med; 2010 Nov; 38(11):2175-80. PubMed ID: 20693888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardioprotective effect of TY-12533, a novel Na(+)/H(+) exchange inhibitor, on ischemia/reperfusion injury.
    Aihara K; Hisa H; Sato T; Yoneyama F; Sasamori J; Yamaguchi F; Yoneyama S; Mizuno Y; Takahashi A; Nagai A; Kimura T; Kogi K; Satoh S
    Eur J Pharmacol; 2000 Sep; 404(1-2):221-9. PubMed ID: 10980282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Levosimendan improves postresuscitation outcomes in a rat model of CPR.
    Huang L; Weil MH; Sun S; Cammarata G; Cao L; Tang W
    J Lab Clin Med; 2005 Nov; 146(5):256-61. PubMed ID: 16242524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of nitric oxide improves coronary perfusion pressure and return of spontaneous circulation in a porcine cardiopulmonary resuscitation model.
    Krismer AC; Lindner KH; Wenzel V; Rainer B; Mueller G; Lingnau W
    Crit Care Med; 2001 Mar; 29(3):482-6. PubMed ID: 11373408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion.
    Humphreys RA; Haist JV; Chakrabarti S; Feng Q; Arnold JM; Karmazyn M
    Am J Physiol; 1999 Feb; 276(2):H749-57. PubMed ID: 9950878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: comparison with other drugs.
    Wajima T; Beguier B; Yaguchi M
    Pharmacology; 2004 Feb; 70(2):68-73. PubMed ID: 14685009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological profile of SL 59.1227, a novel inhibitor of the sodium/hydrogen exchanger.
    Lorrain J; Briand V; Favennec E; Duval N; Grosset A; Janiak P; Hoornaert C; Cremer G; Latham C; O'Connor SE
    Br J Pharmacol; 2000 Nov; 131(6):1188-94. PubMed ID: 11082127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progressive myocardial dysfunction after cardiac resuscitation.
    Tang W; Weil MH; Sun S; Gazmuri RJ; Bisera J
    Crit Care Med; 1993 Jul; 21(7):1046-50. PubMed ID: 8319463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myocardial protection by erythropoietin during resuscitation from ventricular fibrillation.
    Singh D; Kolarova JD; Wang S; Ayoub IM; Gazmuri RJ
    Am J Ther; 2007; 14(4):361-8. PubMed ID: 17667212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Initial defibrillation versus initial chest compression in a 4-minute ventricular fibrillation canine model of cardiac arrest.
    Wang YL; Zhong JQ; Tao W; Hou XM; Meng XL; Zhang Y
    Crit Care Med; 2009 Jul; 37(7):2250-2. PubMed ID: 19455026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators.
    Théroux P; Chaitman BR; Danchin N; Erhardt L; Meinertz T; Schroeder JS; Tognoni G; White HD; Willerson JT; Jessel A
    Circulation; 2000 Dec; 102(25):3032-8. PubMed ID: 11120691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardioprotective effects of the Na(+)/H(+)-exchange inhibitor cariporide in infarct-induced heart failure.
    Spitznagel H; Chung O; Xia Q; Rossius B; Illner S; Jähnichen G; Sandmann S; Reinecke A; Daemen MJ; Unger T
    Cardiovasc Res; 2000 Apr; 46(1):102-10. PubMed ID: 10727658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Augmented efficacy of external CPR by intermittent occlusion of the ascending aorta.
    Tang W; Weil MH; Noc M; Sun S; Gazmuri RJ; Bisera J
    Circulation; 1993 Oct; 88(4 Pt 1):1916-21. PubMed ID: 8403337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myocardial dysfunction after successful resuscitation from cardiac arrest.
    Gazmuri RJ; Weil MH; Bisera J; Tang W; Fukui M; McKee D
    Crit Care Med; 1996 Jun; 24(6):992-1000. PubMed ID: 8681604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A review of the GUARDIAN trial results: clinical implications and the significance of elevated perioperative CK-MB on 6-month survival.
    Chaitman BR
    J Card Surg; 2003; 18 Suppl 1():13-20. PubMed ID: 12691375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model.
    Kupatt C; Hinkel R; Horstkotte J; Deiss M; von Brühl ML; Bilzer M; Boekstegers P
    Cardiovasc Res; 2004 Feb; 61(3):530-7. PubMed ID: 14962483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dantrolene improves survival after ventricular fibrillation by mitigating impaired calcium handling in animal models.
    Zamiri N; Massé S; Ramadeen A; Kusha M; Hu X; Azam MA; Liu J; Lai PF; Vigmond EJ; Boyle PM; Behradfar E; Al-Hesayen A; Waxman MB; Backx P; Dorian P; Nanthakumar K
    Circulation; 2014 Feb; 129(8):875-85. PubMed ID: 24403563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myocardial effects of repeated electrical defibrillations in the isolated fibrillating rat heart.
    Gazmuri RJ; Deshmukh S; Shah PR
    Crit Care Med; 2000 Aug; 28(8):2690-6. PubMed ID: 10966237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation?
    Murakawa Y; Yamashita T; Kanese Y; Omata M
    J Am Coll Cardiol; 1997 Mar; 29(3):688-92. PubMed ID: 9060912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.